AI assistant
Ipca Laboratories Ltd. — Capital/Financing Update 2025
May 2, 2025
61700_rns_2025-05-02_0a5b1817-05dd-4755-b4db-8d7b2e1fc1a7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [105 x 47] intentionally omitted <==
THRU ONLINE FILING
May 2, 2025
BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494
National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB
Dear Sir,
Further to our filing made on 28[th] March, 2025 under Regulation 30 of SEBI (LODR) Regulations, we now wish to inform you that 100% of the paid-up equity share capital of Unichem Laboratories Ltd., Ireland is transferred to Ipca Laboratories Ltd. and, therefore, Unichem Laboratories Ltd., Ireland has now become a wholly owned subsidiary of the Company.
Kindly take this information on your records.
Thanking you
Yours faithfully
For Ipca Laboratories Limited
Digitally signed by Harish Pandurang Kamath DN: c=IN, o=Personal, title=1715, Harish Pandurang pseudonym=585f434c9c014c338904fe5f4cd8762a, 2.5.4.20=955479ec580ea690ffd8de8b74071cf6f1ee247da687a 7ae82030a7ae82c443b, postalCode=400063, st=Maharashtra, Kamath serialNumber=72050fb9fadcbc5de6404685117b8355792f5784c7617d9c4cae2a3887d6b809, cn=Harish Pandurang Kamath Date: 2025.05.02 10:12:24 +05'30'
Harish Kamath Corporate Counsel & Company Secretary
==> picture [445 x 70] intentionally omitted <==